Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Melissa Brammer

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients With Early-Stage Breast Cancer

Value in Health

English

Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States

English

Related publications

Optimal Treatment of Early Stage HER2-positive Breast Cancer

English

Preoperative Axillary Ultrasound in the Selection of Patients With a Heavy Axillary Tumor Burden in Early-Stage Breast Cancer: What Leads to False-Positive Results?

Journal of Ultrasound in Medicine

Nuclear Medicine

Radiology

Ultrasound Technology

English

Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)

English

False-Negative Results of Haemoccult Test.

BMJ

1981

English

Optimizing the Management of HER2-positive Early Breast Cancer: The Clinical Reality

Current Oncology

Oncology

2010

English

Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer

Clinical Breast Cancer

Cancer Research

Oncology

2016

English

Adjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerations

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2013

English

Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor–Positive, HER2-Negative Early Breast Cancer

English

Cost-Utility Analysis of Adjuvant Trastuzumab Therapy for HER2-positive Early-Stage Breast Cancer in the Philippines

BMC Health Services Research

Health Policy

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Melissa Brammer

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients With Early-Stage Breast Cancer

Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States

Related publications

Optimal Treatment of Early Stage HER2-positive Breast Cancer

Preoperative Axillary Ultrasound in the Selection of Patients With a Heavy Axillary Tumor Burden in Early-Stage Breast Cancer: What Leads to False-Positive Results?

Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)

False-Negative Results of Haemoccult Test.

Optimizing the Management of HER2-positive Early Breast Cancer: The Clinical Reality

Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer

Adjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerations

Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor–Positive, HER2-Negative Early Breast Cancer

Cost-Utility Analysis of Adjuvant Trastuzumab Therapy for HER2-positive Early-Stage Breast Cancer in the Philippines